Cosmetic surgery world wide is a billion $ industry, SVFC worth more than 0.3
SVFC HAS to start IND's this year in order to capture a slice of the pie. Cytori and Kool both have their focus. Good points of intellicell is that their method produces a myriad of autologous cells that help to form a construct like matrix, and the other advantage is the low cost and efficiency.
IMO company is worth at least 0.20 by years end, if they can A) Get a international patent, B) form partnerships that will help pay the IND cost, or C) Merge or get bought out.